Christian Simonsson1,2,3, Wolf Claus Bartholomä1,2, Anna Lindhoff Larsson4, Markus Karlsson1, Jens Tellman1, Gunnar Cedersund2,3, Bengt Norén1, Nils Dahlström1,2, Per Sandström4, and Peter Lundberg1,2
1Department of Radiation Physics, Radiology, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden, 2Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden, Linköping University, Linköping, Sweden, 3Department of Biomedical Engineering, Linköping University, Linköping, Sweden, 4Department of Surgery, Department of biomedical and clinical sciences, Linköping University, Linköping, Sweden
Synopsis
Keywords: Liver, Liver, Hepatectomy, Gd-DPTA-EOB, Pharmacokinetic Modeling , Risk assessment
For
a range of late-stage liver disease the only curative treatment option may be
hepatectomy surgery, which can have fatal complications. Therefore, a
pre-operative risk assessment is vital. However, usually the assessment only investigates
global liver function. For a more precise assessment, we investigate the
possibility of using DCE-MRI in combination with pharmacokinetic modeling to
quantify both global- and regional liver function. Also, we show a novel
eight-compartment hepatic model, capable of performing an in-silico
resection. We show the tentative predictive capabilities of this approach. This
approach could lead to a more precise pre-operative assessment.
Introduction
For a range of late-stage liver disease the only
curative treatment option may be hepatectomy surgery. A complication of such
surgery is post-hepatectomy liver failure (PHLF), which has an incidence of
8-12%, and may in some cases be fatal. To minimize the risk of PHLF a
pre-operative risk assessment is performed to assess sufficient function and
volume of the remnant tissue. Usually, liver function assessment only accounts
for global liver function and does not account for any regional variability.
This might be problematic, as regions, or segments, of lower function might not
be identified by global function measurements and be included in the remnant
liver volume. Thus, evaluation of regional function has the potential to generate
a higher degree of individual precision which could benefit the pre-operative
assessment. The use of dynamic contrast enhanced (DCE) MRI to assess
liver function has the possibility to measure regional functionality [1-3]. Herein. we look at
DCE-MRI in combination with pharmacokinetic modelling of the hepatocyte
specific contrast agent, Gd-DPTA-EOB (gadoxetate), to enhance the pre-operative risk assessment
for patients undergoing cancer related hepatectomyMethods
Patients (N=13
fasting) with liver metastases were examined by DCE-MRI (3 T Philips Ingenia) within 3-5 days before
(n=13) and after (m =15) liver resection (Fig. 1A). Patients underwent various
degrees of hepatic resection (Fig. 1B). Many of these very
ill patients declined to undergo a post-surgical research examination due to a severe
physical and mental load. The local
ethics committee approved this study, and written informed consent was obtained
from all patients.
Following a bolus injection (0.025 mmol/kg
body weight) of gadoxetate, images were acquired using an axial breath-hold,
fat-saturated, T1-weighted, 3D gradient echo sequence. Typical image parameters
included flip angle: 10°, repetition time: 4.2 ms, echo time: 2.0 ms, SENSE
factor: 1.7, field of view: 300x200x350 mm3). The post‑injection
images included arterial and portal venous phases, as well as time-series
images acquired e.g., between 0, and 50 minutes (Fig. 1C, left).
In post-processing ROIs were placed in each of
the eight Couinaud segments, plus three ROIs in the spleen, as well as
ROIs in muscle, and portal vein by an experienced radiologist (BN and WB). Signal
intensity measurements were obtained from each ROI, and used to estimate T1
relaxation rate (R1) and concentration of gadoxetate for each compartment (Fig.
1C, middle).
The dataset was then used to train our novel
eight-compartment dynamic ODE model (Fig. 1C, right) describing the
hepatobiliary fluxes of gadoxetate for each segment. This yielded segment,
patient and examination-specific influx rates ki. By using
the model ‘preform’ an in silico resection, using the datasets of patients
having both pre-and post-examination data, we could assess any difference in
uptake rate between examinations, this was quantified using the parameter kstress. Results
The
model fit for the in silico resection for patient1 can be seen in Fig.
2A. Using this approach, we could quantify the difference in uptake function
pre-and post-surgery (Fig. 2B). The difference in influx rate, kstress,
pre-and post-surgery was quantified for all patients who underwent both
examinations (Fig. 2C).
Next,
we wanted to make model prediction using only information from before the
surgery (Fig. 3A). In silico resections were ‘performed’ by training the
model on only pre-surgery data and using a kstress value that
matched the extent of resection (Fig. 3B). The corresponding model predicted gadoxetate concentration post-surgery can be seen in Fig. 3C. The predicted
change in influx can be seen in Fig. 3D. As a tentative validation we compared
the new predicted influx with other measure of liver function, e.g., Bilirubin
and PT-INR (Fig. 3E). The predicted drop in influx for patient2, corresponds to
a higher bilirubin value, which correlates to the trend seen in patient 1 and
6. This tentatively shows the predictive capabilities of our approach.
To
show model usability, we show the resection scenario of patient1 (Fig. 4A).
Here we highlight two examples which would lead to higher uptake after surgery.
Example 1; re-adding segment four, and example 2 increased function.
Simulations for each segment during these scenarios are shown in Fig. 4B, and
the total hepatic gadoxetate in Fig. 4C-D. To show further capabilities of
using a model-based approach, we highlight the possibility of simulating any
type of resection (Fig. 5A). Corresponding simulations are shown in Fig. 5B, where
yellow lines are simulations where segment are removed in order 1 to 8, and
blue lines order 8 to 1. In Fig. 5C we highlight the possibility of freely changing
the function of individual segments, simulations of concentration of individual
segments in Fig. 5D and total liver in Fig. 5E. Changing function in larger
segments yields larger effect on the total concentration. Discussion
Herein,
we present a novel approach of combining DCE-MRI assessment of liver function
with an eight-compartment ODE model. We show that the approach has tentative
predictive capabilities worth exploring further. There are a lot of
limitations, and more validation will be needed to determine if the approach
could be used for any clinical application.
In
conclusion, the work shown herein is a step toward better pre-operative
assessments which would help limit surgical complications for already very
late-stage patients. References
1. Nilsson, H., et al., Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. HPB, 2010. 12(8): p. 567-576.
2. Zhou, Z.-P., et al., Evaluating segmental liver function using T1 mapping on Gd-EOB-DTPA-enhanced MRI with a 3.0 Tesla. BMC Medical Imaging, 2017. 17(1): p. 20.
3. Truhn, D., et al., A New Model for MR Evaluation of Liver Function with Gadoxetic Acid, Including Both Uptake and Excretion. European Radiology, 2019. 29(1): p. 383-391.